Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
The Scientist
Most Recent
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
More than half of pharmaceutical companies on Twitter use more than one handle.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
